Payments to Acquire Property, Plant, and Equipment of Atara Biotherapeutics, Inc. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Atara Biotherapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • Atara Biotherapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $0, a 100% decline from 2024.
  • Atara Biotherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $246,000, a 80% decline from 2023.
  • Atara Biotherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1,223,000, a 71% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Atara Biotherapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $0 -$246,000 -100% 01 Jan 2025 31 Dec 2025 10-K 16 Mar 2026 2025 FY
2024 $246,000 -$977,000 -80% 01 Jan 2024 31 Dec 2024 10-K 16 Mar 2026 2025 FY
2023 $1,223,000 -$2,970,000 -71% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2025 2024 FY
2022 $4,193,000 -$6,387,000 -60% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $10,580,000 +$6,067,000 +134% 01 Jan 2021 31 Dec 2021 10-K 08 Feb 2023 2022 FY
2020 $4,513,000 -$1,220,000 -21% 01 Jan 2020 31 Dec 2020 10-K 08 Feb 2023 2022 FY
2019 $5,733,000 -$30,192,000 -84% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $35,925,000 +$15,693,000 +78% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $20,232,000 +$17,212,000 +570% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $3,020,000 +$2,730,000 +941% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $290,000 +$244,000 +530% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $46,000 +$43,000 +1433% 01 Jan 2014 31 Dec 2014 10-K 09 Mar 2017 2016 FY
2013 $3,000 01 Jan 2013 31 Dec 2013 10-K 04 Mar 2016 2015 FY

Atara Biotherapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$127,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $127,000 -$272,000 -68% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $399,000 -$2,206,000 -85% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $2,605,000 +$408,000 +19% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $2,197,000 +$864,000 +65% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $1,333,000 +$537,000 +67% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $796,000 -$19,012,000 -96% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $19,808,000 +$18,602,000 +1542% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $1,206,000 +$315,000 +35% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $891,000 +$886,000 +17720% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q1 2015 $5,000 -$995,000 -100% 01 Jan 2015 31 Mar 2015 10-Q 06 May 2016 2016 Q1
Q1 2014 $1,000,000 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q4 2012 $9,000 22 Aug 2012 31 Dec 2012 10-K 26 Feb 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.